Cancer contributes to 9.6 million deaths worldwide and 16,000 deaths in Malaysia. According to Malaysian National Cancer Registry (MNCR) 2012-2016, prostate cancer is also part of the 10 highest cancers detected among Malaysians.
Prostate malignant growth is delegated as adenocarcinoma, or glandular cancer, that starts when typical semen-emitting prostate organ cells transform into malignancy cells. The area of prostate gland where the adenocarcinoma is most regular is the peripheral zone. The malignancy cells may metastasize from the prostate to different parts of the body especially the bones and the lymph nodes. It may cause:
- difficulty in urinating,
- problems during sexual intercourse, or
- erectile dysfunction.
As reported in Health Technology Assessment Report: Prostate Cancer Screening by Ministry of Health (MOH), the principal mass screening test for early detection of prostate cancer is Prostate Specific- Antigens (PSA). The reference standard for this test is histological confirmation of cancer.
It is also reported in Health Technology Assessment Report: Prostate Cancer Screening by Ministry of Health (MOH) that in general, the agents which cause the initiation of prostate cancer is unknown.
- Age is considered an important risk factor. The risk for developing prostate cancer increases with age, beginning to be significant at the age of 50 with a steep rise after the age of 65.
- Family history is a determinant of risk, with relative risk values between two and three for men who had a father or brother with prostate cancer.
The PSA test is a blood test that gauges the measure of Prostate Specific- Antigens (PSA) in your blood. PSA is a protein produced by common cells in the prostate and furthermore by prostate malignancy cells. It’s not unexpected to have a limited quantity of PSA in your blood, and the amount rises marginally as you age and the size of the prostate gets bigger. A raised PSA level may recommend you a complication of your prostate, yet not necessarily cancer.
In Beacon Hospital, we urge you to get screened if you are having any of the following symptoms:
- Blood in the urine
- Painful ejaculation
- Difficulty in urinating
- Incomplete bladder emptying
- The urge for more frequent urination
- Pain in the bones due to cancer metastasis to the bone
Our intention of getting you to proactively screened for prostate cancer is to decrease mortality and increase your quality of life. Beacon Hospital is now offering Free Prostate Specific- Antigens (PSA) to increase the awareness on the importance of screening for early detection of prostate cancer as most cases does not have any symptoms.
Terms and Conditions:
- This CSR programme is valid from 1st December 2020 to 31st March 2021.
- This CSR programme is applicable to men aged 55 years old and above.
- This CSR programme is limited to the first 300 customers only.
- This CSR programme includes a complimentary Prostate-Specific Antigen (PSA) test and reporting fee.
- This CSR programme excludes registration fee of RM18 for new patient and RM6 for existing patient, follow-up consultation and other additional tests/medications/procedures.
- This CSR programme is valid for self-pay customers only.
- Customers are required to make prior appointment for the consultation.
- Beacon Hospital reserves all rights to amend these terms & conditions without prior notice.